ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION

Chicago, IL, US
501(c)3
EIN
02-0464400

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION

Chicago, IL, US
501(c)3
EIN
02-0464400

Balance Sheet

Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)

$112,814,085

Investments
66%
Receivables (Non-Related)
19%
Cash & Equivalents
12%
Other Assets
1%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)

$71,680,288

Deferred Revenue
78%
Payables & Accruals
22%
Other Liabilities
<1%
Custodial & Escrow Liabilities
<1%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$21,526,271
$13,952,645
-35%
Receivables (Non-Related)
$13,159,026
$21,681,875
+65%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$477,043
$543,162
+14%
Investments
$81,268,729
$74,765,368
-8%
Property, Plant, & Equipment (net)
$177,893
$510,406
+187%
Other Assets
$1,523,470
$1,360,629
-11%
Total Assets
$118,132,432
$112,814,085
-5%
Liabilities
2023
2024
Change
Payables & Accruals
$9,341,200
$15,530,043
+66%
Grants Payable
-
-
-
Deferred Revenue
$65,374,417
$55,870,958
-15%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
$152,661
$115,105
-25%
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$254,269
$164,182
-35%
Total Liabilities
$75,122,547
$71,680,288
-5%
Net assets
2023
2024
Change
Restricted Net Assets
$3,866,558
$3,413,797
-12%
Unrestricted Net Assets
$39,143,327
$37,720,000
-4%
Net assets
2023
2024
Change
Net assets
+$43,009,885
+$41,133,797
-4%
Balance Sheet
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)